Next Generation Dx Summit

Next Generation Dx Summit

August 20-24, 2018
Grand Hyatt Washington, Washington, DC
Exhibit booth #105

Meet with Flagship at the Next Generation Dx Summit to discover how we help oncology drug developers define their path to success. Our Computational Tissue Analysis (cTA®) approach provides the quantitative, contextual data needed to make confident clinical trials decisions. We partner with drug developers to implement tissue-based biomarker strategies and drive efficient and effective clinical trials.

On Tuesday, August 21, 12:30-1:00 pm, Flagship Chief Scientific Officer Joseph Krueger, Ph.D., will present during the Biomarkers for Cancer Immunotherapy and Combinations program in meeting room Constitution (C, D, E).

Connect with Flagship

Schedule a Meeting at Next Generation Dx Summit

To set up a time to meet with a member of our team, please send us your availability and a brief description of your needs in tissue-based biomarker evaluations.
Schedule a Meeting

About the Next Generation Dx Summit

The Next Generation Dx Summit offers unparalleled insight through comprehensive programming and networking with key opinion leaders in the industry. This year the coverage spans cell and cell-free biopsies, commercialization, reimbursement, biomarkers and companion diagnostics for immunotherapy, point-of-care testing, infectious disease, micro fluids and precision medicine.

Visit the Next Generation Dx Summit website
Follow Flagship on Twittter: @FlagshipBio